<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02866396</url>
  </required_header>
  <id_info>
    <org_study_id>SPH-016-A</org_study_id>
    <nct_id>NCT02866396</nct_id>
  </id_info>
  <brief_title>Impact of Pregabalin in Chronic Users vs. a Perioperative Limited Prescription on Oxycodone Requirement</brief_title>
  <acronym>PREGAB</acronym>
  <official_title>Postoperative Oxycodone Consumption After Spinal Surgery in Pregabalin-treated Patients Compared to a 48-h Perioperative Administration: a Prospective, Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Christophe Aveline, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Private Hospital Sevigne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal surgery is associated with intense pain and associated to a history of preoperative
      chronic pain. Pregabalin is licensed to treat chronic neuropathic pain, particularly when
      high dose of opioid are required. Preoperative pain is associated with high postoperative
      pain scores and opioid requirement promoting persistent hyperalgesic state. The investigators
      will evaluate the postoperative opioid consumption and pain scores in patients scheduled for
      lumbar surgery and taking pregabalin since more than 15 days and compare with preoperative
      pregabalin-free patient that will receive pregabalin only during surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be prospectively included and compared according their preoperative medication:
      pregabalin-treated patients (&gt;more than 15 days) for neuropathic pain associated to spinal
      surgery and pregabalin-free patients for whom pregabalin will be prescribed for 48 hours.
      Patients will be included without randomization as an observational study. All the patients
      will receive multimodal analgesia and intraoperative management will be standardized. The
      main outcome will be the amount of oxycodone during the first 24h after surgery. Other
      outcomes include pain scores, the quantification of the neuropathic pain diagnostic
      questionnaire (DN4), nausea and vomiting, length of stay, side-effects of pregabalin and
      opioid. Patients were also evaluated at three months for pain scores and DN4 score.
      Postoperative evaluation will be performed in a single-blind manner with investigators not
      include in the recruitment or the peroperative period.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2016</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Oxycodone consumption</measure>
    <time_frame>24h postoperatively</time_frame>
    <description>mg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale (NRS) Pain at rest</measure>
    <time_frame>the day before surgery</time_frame>
    <description>NRS: 0 no pain - 10 worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale (NRS) Pain during walking</measure>
    <time_frame>the day before surgery</time_frame>
    <description>NRS: 0 no pain - 10 worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale Pain (NRS) at rest</measure>
    <time_frame>1h after surgery</time_frame>
    <description>NRS: 0 no pain - 10 worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale Pain (NRS) at rest</measure>
    <time_frame>4h after surgery</time_frame>
    <description>NRS: 0 no pain - 10 worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale Pain (NRS) at rest</measure>
    <time_frame>8h after surgery</time_frame>
    <description>NRS: 0 no pain - 10 worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale Pain (NRS) at rest</measure>
    <time_frame>12h after surgery</time_frame>
    <description>NRS: 0 no pain - 10 worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale Pain (NRS) at rest</measure>
    <time_frame>24h after surgery</time_frame>
    <description>NRS: 0 no pain - 10 worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale Pain (NRS) at rest</measure>
    <time_frame>48h after surgery</time_frame>
    <description>NRS: 0 no pain - 10 worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale Pain (NRS) at rest</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>NRS: 0 no pain - 10 worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale Pain (NRS) during walking</measure>
    <time_frame>12h after surgery</time_frame>
    <description>NRS: 0 no pain - 10 worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale Pain (NRS) during walking</measure>
    <time_frame>48h after surgery</time_frame>
    <description>NRS: 0 no pain - 10 worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale Pain (NRS) during walking</measure>
    <time_frame>3 months ater surgery</time_frame>
    <description>NRS: 0 no pain - 10 worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>remifentanil consumption</measure>
    <time_frame>during surgery</time_frame>
    <description>Âµg/kg/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morphine titration</measure>
    <time_frame>0-2h after surgery</time_frame>
    <description>mg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxycodone requirement</measure>
    <time_frame>0-48h after surgery</time_frame>
    <description>mg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ondansetron requirement</measure>
    <time_frame>0-48h after surgery</time_frame>
    <description>mg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DN4 score</measure>
    <time_frame>preoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DN4 score</measure>
    <time_frame>on postoperative day one</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DN4 score</measure>
    <time_frame>on postoperative day two</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DN4 score</measure>
    <time_frame>three months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of stay</measure>
    <time_frame>on postoperative day five</time_frame>
    <description>days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post Opertive Nausea and vomiting (PONV)</measure>
    <time_frame>0-48h after surgery</time_frame>
    <description>% of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregabalin side-effects</measure>
    <time_frame>0-48h after surgery</time_frame>
    <description>diplopia, confusion, dizziness, psychiatric disorders (% of patients)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation</measure>
    <time_frame>0-48h after surgery</time_frame>
    <description>1: awake - 2: drowsiness, easily awake by appeal - 3: drowsiness, awake to tactile stimulation - 4: drowsiness, awake by pain</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">70</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Neuropathic Pain</condition>
  <arm_group>
    <arm_group_label>Pregabalin patients</arm_group_label>
    <description>Same dose of preoperative pregabalin 1h after surgery associated to paracetamol 1g PO and ketoprofen 100mg PO Intraoperative: nefopam 20mg IV + ketamine 0.3mg/kg IV + dexamethasone 8mg IV Postoperative: morphine titration (PACU if NRS &gt; 3) + paracetamol 1g/6h PO + ketoprofen 100mg/12h PO systematically, oxycodone 5-10mg/12h PO if NRS&gt;3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Naive patients</arm_group_label>
    <description>Pregabalin 150mg PO initiated 1h before surgery and associated to paracetamol 1g PO and ketoprofen 100mg PO Intraoperative: nefopam 20mg IV + ketamine 0.3mg/kg IV + dexamethasone 8mg IV Postoperative: morphine titration in PACU (NRS &gt; 3) + paracetamol 1g/6h PO + ketoprofen 100mg/12h PO systematically, oxycodone 5-10mg/12h PO if NRS&gt;3</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>Pregabalin continued at the same preoperative dose 1h before surgery associated to paracetamol 1g PO and ketoprofen 100mg PO Intraoperative: nefopam 20mg IV + ketamine 0.3mg/kg IV + dexamethasone 8mg IV Postoperative: morphine titration in PACU (NRS &gt; 3) + paracetamol 1g/6h PO + ketoprofen 100mg/12h PO systematically, oxycodone 5-10mg/12h PO if NRS&gt;3</description>
    <arm_group_label>Pregabalin patients</arm_group_label>
    <other_name>ATC code: N03AX16</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Naive patient</intervention_name>
    <description>Pregabalin 150mg PO initiated 1h before surgery Associated to paracetamol 1g PO and ketoprofen 100mg PO Intraoperative: nefopam 20mg IV + ketamine 0.3mg/kg IV + dexamethasone 8mg IV Postoperative: morphine titration in PACU (NRS &gt; 3) + paracetamol 1g/6h PO + ketoprofen 100mg/12h PO systematically, oxycodone 5-10mg/12h PO if NRS&gt;3</description>
    <arm_group_label>Naive patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The investigators will evaluate the postoperative opioid consumption and pain scores in
        patients scheduled for lumbar spine surgery and taking pregabalin since more than 15 days
        and compare with preoperative pregabalin-free patient that will receive pregabalin only
        during surgery.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society Anesthesiologist Physical status (ASA) 1-3

          -  Age â¥18 years old

          -  Spinal surgery: discectomy, posterior or transforaminal lumbar interbody fusion
             limited to 2 levels, lumbar disk prosthesis

          -  Able to participate personality, has given free and inform consent in French

          -  Affiliated of beneficiary of a system of social security

        Exclusion Criteria:

          -  Age less than 18 years or higher than 85 years old

          -  Refusal to participate or provide written consent

          -  Surgery with a combined anterior and posterior approach

          -  Emergency surgery, reintervention, spine fracture, metastasis

          -  Tricyclic antidepressant use

          -  Pregabalin use for other indication: other neuropathy, epilepsy, generalized anxiety
             disorder

          -  Pregnancy

          -  Lack of understanding of NRS and/or DN4 scores

          -  Hypersensibility or contraindication to levobupivacaine, paracetamol, nefopam,
             ketoprofen and/or oxycodone

          -  Participation in another clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>HÃ©lÃ¨ne Beloeil, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christophe Aveline, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Private Hospital Sevigne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Christophe Aveline, MD</name>
      <address>
        <city>Cesson Sevigne</city>
        <zip>35510</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2016</study_first_submitted>
  <study_first_submitted_qc>August 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2016</study_first_posted>
  <last_update_submitted>March 31, 2018</last_update_submitted>
  <last_update_submitted_qc>March 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Private Hospital Sevigne</investigator_affiliation>
    <investigator_full_name>Christophe Aveline, MD</investigator_full_name>
    <investigator_title>Principal investigator: Christophe Aveline, Department of anesthesia and surgical intensive care unit, Private Hospital</investigator_title>
  </responsible_party>
  <keyword>chronic pain</keyword>
  <keyword>oxycodone</keyword>
  <keyword>pregabalin</keyword>
  <keyword>lumbar spine surgery</keyword>
  <keyword>multimodal analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ketoprofen</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Pregabalin</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Nefopam</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

